The market is pricing the stock in line with historical averages, assuming steady-state growth.
Fragile underlying quality score of 18/100; weak margins or elevated debt leverage warrant caution.
Analysts remain cautious, with consensus price targets indicating limited room for upside expansion.
Verdict: Highly distressed profile flashing severe fundamental warning signs.
Wall Street is cautious, forecasting potential downside alongside robust expected earnings growth. The company currently dilutes shareholders to fund operations and growth rather than returning capital.
PSNY struggles with subpar profitability and pressured margins. This is paired with a moderately leveraged but stable balance sheet.
The company demonstrates solid revenue growth (7.8% 3Y CAGR) paired with stable bottom-line earnings. However, profitability remains a major concern with severely compressed operating margins (-95.8%).
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $711.3M | +50.3% | +7.8% | +38.0% | — | |
| EBITDA | -$545.9M | — | -35.7% | — | — | |
| Net Income | -$596.5M | -15.0% | -70.1% | — | — | |
| EPS (Diluted) | $-8.40 | +12.4% | — | — | — | |
| Free Cash Flow | -$292.8M | +22.2% | +16.5% | -28.4% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | -32.5% | -32.0% | -18.0% | -3.4% |
| Operating Margin | -95.8% | -72.1% | -65.1% | -86.4% |
| Net Margin | -89.0% | -76.0% | -64.5% | -88.1% |
| FCF Margin | -57.7% | -62.0% | -58.5% | -122.4% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $-1.68 | $-4.14 | -145.8% | ||
| Q3'25 | $-0.12 | $-8.46 | -6779.8% | ||
| Q2'25 | $-0.13 | $-1.07 | -723.1% | ||
| Q2'25 | $-0.12 | $-8.46 | -6893.5% | ||
| Q1'25 | $-0.15 | $-0.15 | +0.0% | ||
| Q3'24 | $-0.18 | $-0.14 | +22.2% | ||
| Q3'24 | $-0.13 | $-0.35 | -169.2% | ||
| Q2'24 | $-4.52 | $-9.90 | -119.3% |
Total return is +1758.3% (1Y), outperforming the benchmark by +1733.3%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +1.3% | -8.0% | — |
| 1Y | +1758.3% | +1733.3% | — |
| 3YCAGR | +72.5% | +54.2% | — |
| 5YCAGR | +15.4% | +3.4% | — |
| 10YCAGR | +7.2% | -6.2% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Polestar Automotive Holding UK PLC (PSNY) valuation, health, and returns.
Polestar Automotive Holding UK PLC is estimated to be fairly valued under our discounted cash flow framework. trading near fair value (DCF: $0.00)
Polestar Automotive Holding UK PLC has multiple valuation anchors: DCF Intrinsic Value: $0.00 | Wall Street Analyst Target: $15.00 (implying -25.3% upside). A convergence of these signals offers higher conviction.
Polestar Automotive Holding UK PLC displays poor financial health with a composite quality score of 18/100, supported by a Altman Z-Score of -6.2 (distress zone), Piotroski F-Score of 3/9, Return on Invested Capital (ROIC) of -262.7%.
Polestar Automotive Holding UK PLC does not return material capital to shareholders via dividends or share repurchases, electing to retain earnings to fund internal growth.
Polestar Automotive Holding UK PLC's current growth trajectory is Accelerating. The company achieved +50.3% 1Y revenue growth and +12.4% 1Y EPS growth, compared to its 3Y revenue CAGR of +7.8%.
Wall Street consensus is Sell based on 5 analysts, beating EPS expectations in 25% of recent quarters with a -5-quarter streak. The consensus price target represents a -25.3% change from current levels.
Investment risks for Polestar Automotive Holding UK PLC include: -61.8% 1-year max drawdown, elevated distress risk. Volatility risk is characterized by a beta of 0.96x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.